جست‌وجوی استاد و پژوهشگر

Mohamed Hassanمشاهده پروفایل

استادیار

• Computer Architecture
• Embedded Systems
• Real-Time Systems
• +۱۲ مورد دیگر

Dr. Mohamed Hassan is an Assistant Professor in the Department of Electrical & Computer Engineering at McMaster University. His research focuses on Cyber-Physical Systems-on-Chip (iCPSoCs) , emphasizing design, analysis, and deployment for critical domains like Unmanned Aerial Vehicles (UAVs), Autonomous Cars, and healthcare systems. Key research areas include hardware/software codesign, real-time systems, embedded systems, and security. He teaches courses such as COMPENG 4DM4 (Computer Architecture) and COMPENG 4DS4 (Embedded Systems) . His work bridges foundational theories (e.g., scheduling, AI) with infrastructure-level innovations (e.g., compilers, memory systems). The Fanos Research Lab he leads explores interdisciplinary solutions for efficient CPS-on-Chip, addressing challenges in multicore predictability, memory latency, and edge computing. Recent contributions include frameworks for explainable memory-centric workloads and techniques to accelerate TinyML inference. Dr. Hassan serves on Technical Program Committees for conferences like RTAS and OSPERT, highlighting his role in advancing real-time embedded systems research.

Vita Goeiمشاهده پروفایل

دانشیار

• Molecular Biology
• Pediatric Gastroenterology
• Liver Disease
• +۳ مورد دیگر

Vita Goei is an Associate Professor at the Medical College of Georgia within Augusta University , specializing in Pediatrics with a focus on Pediatric Gastroenterology . Holding an MD from Albert Einstein College of Medicine (1986) and a BA in Biology from Yeshiva University (1979) , she has practiced pediatric gastroenterology since 1996. Education: MD, Albert Einstein College of Medicine (1986) BA, Yeshiva University (1979) Her research career began in molecular biology with seminal work on the GABA(B) receptor gene and MHC class I transcription . She now seeks clinical studies in pediatric GI, particularly liver disease, Cystic Fibrosis , Inflammatory Bowel Disease , and Eosinophilic Esophagitis . Recent publications span antimicrobial therapy, genetic variants, and diagnostic case studies. Certifications: Basic Life Support (AHA, 2023) Georgia Composite Medical Board (2000) Professional service includes continuous affiliation with the Department of Pediatrics (Gastroenterology) since 2007, previously serving in the same department from 2000-2007.

Craig Morrellمشاهده پروفایل

استاد

• Platelet Biology
• Vascular Inflammation
• Thrombosis
• +۵ مورد دیگر

Craig Morrell is a Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Medicine , Microbiology and Immunology , and Pathology and Laboratory Medicine . He serves as Associate Director of the Aab Cardiovascular Research Institute . Education: Sc.B. in Biology, Brown University (1995) D.V.M. , Tufts University School of Veterinary Medicine (2000) Ph.D. in Pathobiology, Johns Hopkins University (2005) His research examines the interface between platelets, vascular biology, and immune cells , focusing on platelet roles in thrombosis, inflammation, and immune regulation. Using advanced mouse models , his lab investigates platelet-derived mediators like β2M and PF4 in diseases such as malaria, stroke, and myocardial infarction. Article trends highlight platelets' dual roles in thrombosis and immune modulation , with recurring themes in vascular inflammation , ERK5 signaling , and age-related immune dysfunction . Scientific Awards: Kenneth M. Brinkous Young Investigators Prize (2008) Deans Gift research award (2006) Multiple travel scholarships and fellowships (2003-2005) Pathology Award-Excellence in Pathology (2000) Mentoring and Teaching : He has mentored 8 doctoral students , 7 undergraduates , and 6 postdoctoral fellows , with a focus on diversity. He serves on thesis committees and the URMC MSTP (MD/PhD) admissions committee . Labs and Collaborations : Leads the Morrell Lab at the Aab Cardiovascular Research Institute, collaborating with institutions like Johns Hopkins and Medical College of Wisconsin.

Maxim Artyomovمشاهده پروفایل

استاد

• Systems Immunology
• Immunometabolism
• Cancer Immunology
• +۲ مورد دیگر

Maxim Artyomov is an Alumni Endowed Professor and Professor of Pathology and Immunology at Washington University School of Medicine , with affiliations to the Institute of Clinical and Translational Sciences (ICTS), Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs), and Siteman Cancer Center. His research spans Systems Immunology , Immunometabolism , and Cancer Immunology , focusing on integrating epigenetic, transcriptional, and metabolic regulation in immune cells. 2018 promoted to Associate Professor with Tenure 2017 awarded LEAP Inventor Challenge 2018 Unanue Prize for Innovative Research in Immunology Key research contributions include: Discovery of itaconate's anti-inflammatory role (2016) Metabolic reprogramming in macrophage polarization (2015) TREM2's function in microglial metabolic fitness (2017) Development of CORESH gene signature search engine (2025) His high-throughput omics pipelines enable cross-disciplinary analysis of immune responses in tuberculosis, Alzheimer's, and cancer. Notable collaborations include work with Schreiber's lab on immune checkpoint therapy (2018) and ITMO University on systems biology workshops (2017-2018). Awards and grants include the Unanue Prize (2018), LEAP Inventor Challenge (2017), and R01 grant from NIAID (2017). He mentors PhD/MSTP students and co-organizes international systems biology workshops.

Hans-Gustaf Ljunggrenمشاهده پروفایل

استاد

• Tumor immunity
• Infection immunity
• Innate immunity
• +۳ مورد دیگر

Hans-Gustaf Ljunggren is Professor and Senior Physician at the Department of Medicine, Huddinge, Karolinska Institutet (KI) in Sweden, where he has served since 2001. In parallel he founded and directs the Center for Infectious Medicine (CIM) . He is additionally a part-time visiting professor at Nova Southeastern University, USA (2017-2019), and an elected member of the Academia Europaea (2023). Education & Training: MD and PhD, Karolinska Institutet, 1982-1992 Post-doctoral fellowship, Center for Cancer Research, MIT, Boston, USA, 1992-1994 Research Focus His group investigates human immune responses in cancer and infectious diseases , with emphasis on natural-killer (NK) cell biology, innate and adaptive immunity, and immunotherapeutic applications. Major themes include: NK-cell reactivity against tumors and NK-cell–based cancer immunotherapy Immunity to flaviviruses (TBEV, JEV, YFV) and SARS-CoV-2 Vaccine immunogenicity in healthy and immunocompromised populations Genetic and functional studies of cytotoxic lymphocyte defects Scientific Awards & Honors Cancer Research Institute Post-Graduate Fellowship, New York (1990) J William Fulbright Foreign Scholarship Award (1992) Distinguished Professor Recognition, Karolinska Institutet (2010) Tobias Foundation Prize, Royal Swedish Academy of Sciences (2011) Medal for Zealous and Devoted Service to the Swedish Government (2020) Leadership & Service Prof. Ljunggren has held numerous leadership roles at KI, including member of the Nobel Assembly, Dean of Research (2013-2016), and currently Director of the NextGenNK Competence Center founded by Sweden’s Innovation Agency. He has served on editorial boards, national grant panels, and as scientific secretary of the Swedish Cancer Society.

Ellen Robeyمشاهده پروفایل

استاد

• Immunology
• Molecular Biology
• Cell Biology
• +۳ مورد دیگر

Ellen Robey is a Professor of Immunology and Molecular Medicine at the University of California, Berkeley, serving as Division Head of the IMM Division. Her research focuses on signaling pathways controlling T cell fate decisions, using mouse models to study T cell development and immune responses, including mechanisms of thymic selection and CD4/CD8 lineage commitment. She employs 2-photon imaging to analyze T cell behavior in situ, particularly during parasitic infections like Toxoplasma gondii . Robey’s lab investigates how self-reactivity influences thymic selection timing and develops collaborative projects combining multi-omics approaches with spatial and temporal analyses of thymic development. Key research areas include understanding negative/positive selection mechanisms in the thymus, immune response dynamics during chronic infections, and the role of unconventional T cell subsets recognizing non-classical MHC molecules. The lab has pioneered studies on Qa1-restricted T cells and their role in host defense against pathogens. Her work bridges basic immunology with cutting-edge imaging and systems biology tools to unravel complex immune processes. Lab collaborations include projects with Nir Yosef and Aaron Streets to create high-resolution thymic developmental maps using single-cell multi-omics. Current efforts also explore how ERAAP downregulation alters antigen presentation, influencing T cell responses. The Robey Lab emphasizes diversity in its team, fostering an inclusive environment for scientific innovation.

Xiaolin Zhuمشاهده پروفایل

مدرس

• human genetics
• medical genetics
• cancer genetics
• +۷ مورد دیگر

Xiaolin Zhu, MD, PhD is an Adjunct Lecturer in the School of Medicine at the University of California, San Francisco (UCSF), specializing in the Genitourinary Medical Oncology Program. His clinical focus is on prostate, bladder, and kidney cancers, while his research explores cancer evolution mechanisms through patient biospecimen analysis. He holds roles as Principal Investigator on grants from the Department of Defense, Prostate Cancer Foundation, and Conquer Cancer Foundation. Education: Bachelor of Medicine (MD equivalent) in Clinical Medicine, Shanghai Jiao Tong University School of Medicine (2011) PhD in Genetics and Genomics, Duke University (2017) Internal Medicine Residency, UT Southwestern Medical Center (2020) Hematology/Oncology Fellowship, UCSF (2024) Research Interests: Focuses on precision oncology, genomic profiling of treatment resistance, and translational research in prostate and urothelial cancers. Key areas include epigenetic evolution in cancer progression, biomarker discovery, and developing novel therapeutic strategies. Awards: ASCO Young Investigator Award (2022-2023) PCF Young Investigator Award (2022-2025) Department of Defense Physician Research Award (2024-2028) Grants: Investigating SSTR1 as a novel biomarker for advanced prostate cancer (DOD, 2024-2028) Resistance mechanisms to androgen receptor inhibitors (PCF, 2022-2025) Genomic profiling of metastatic castration-resistant prostate cancer (ASCO, 2022-2023) Labs/Teams: Active in UCSF's Genitourinary Oncology research teams and collaborates with the West Coast Prostate Cancer Dream Team.

• Liver Immunology
• Immune Tolerance
• Transplant Immunology
• +۵ مورد دیگر

Associate Professor Patrick Bertolino at the University of Sydney's Central Clinical School leads the Liver Immunology Program at the Centenary Institute. With 20+ years of international recognition in liver immunology , he pioneered discoveries about CD8+ T cell activation and hepatocyte-mediated immune tolerance , including the paradigm-shifting finding that liver-activated T cells are deleted via hepatocyte lysosomes. His work bridges transplantation immunology , chronic hepatitis , and malaria vaccine development using transgenic mouse models . Trained by immunology luminaries: Chantal Rabourdin-Combe (ENS-Lyon), Jacques Miller (WEHI), Barbara Fazekas de St Groth (Centenary Institute) Continuous NHMRC funding since 2000: 2 Program Grants, 6 Project Grants 2010 NHMRC Senior Research Fellowship Research Themes explore how the liver uniquely regulates immunity: Induces transplant tolerance via T cell deletion Exploits immune subversion in hepatitis B/C and malaria Develops gene therapy and mRNA vaccines for liver-targeted immunity Investigates hepatitis C reinfection post-transplant Article Trends show sustained focus on T cell-liver interactions , with recent work on mRNA vaccines (2023), neuroinflammation in GVHD (2024), and long-lived TRM cells in malaria (2025). Publications span high-impact immunology , hepatology , and transplantation journals . Awards include: 2010 NHMRC Senior Research Fellowship 2009 Centenary Institute student paper award 1999 Kevin Lafferty Prize for Autoimmunity 1997 University of Sydney U2000 Fellowship Teaching includes 3rd-year Immunology lectures (since 1998). Led liver immunology group since 2011, mentoring students and postdocs. Collaborates with Centenary Institute and National Hepatitis C Elimination Program .

Phyllis Fung-Yi Cheungمشاهده پروفایل

پژوهشگر

• Tumor Heterogeneity
• Drug Resistance
• Cancer Immunology
• +۴ مورد دیگر

Dr. Phyllis Fung-Yi Cheung is a researcher at the German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, affiliated with University Hospital Essen. Her work focuses on spatiotemporal tumor heterogeneity and therapy-induced dynamics in the tumor microenvironment (TME), particularly in solid cancers like pancreatic and hepatocellular carcinoma. Research Interests : Therapy-induced dynamics in tumor microenvironment Spatial multi-omic analysis of cancer-associated fibroblasts Translational applications for drug resistance in solid tumors Publication Trends : Her research spans drug resistance mechanisms, cancer immunology, and TME interactions. Key areas include pancreatic cancer, hepatocellular carcinoma, fibroblast activation, and immune evasion strategies using progranulin and MHCI regulation. Scientific Awards : AIO Science Award 2022 Labs & Collaborations : Leads the DKTK research group on spatiotemporal tumor heterogeneity, collaborating across institutions to integrate dynamic and spatial heterogeneity studies for precision oncology.

Asolina Braunمشاهده پروفایل

پژوهشگر ارشد

• Skin Immunology
• Autoimmunity
• Psoriasis
• +۷ مورد دیگر

Dr. Asolina Braun is a Senior Research Fellow at the Department of Biochemistry & Molecular Biology, Monash University. She actively supervises PhD students and contributes to research in Skin Immunology Psoriasis Pathogenesis Immunopeptidomics Tissue-Resident Memory T Cells . Education : Biology, Hannover Medical School Doctoral Degree in Immunology (Hannover Medical School, Germany, 2011–2014) Postdoctoral Fellowship with Francis Carbone and Thomas Gebhardt (Germany, 2014–2018) Research Focus : Her work explores HLA-Cw6-dependent antigen presentation and TRM cell survival factors in psoriasis, aiming to develop tolerization strategies for autoinflammatory skin diseases. She also pioneered tactile science communication methods for psoriasis outreach. Key Projects : Leading Psoriasis Antigen Triggers (2023–2025) Investigating Influenza Immune Cross-Protection (2024–2027) Validating HLA-Cw6 Antigen Presentation (2020–2022) Awards & Roles : DFG Fellowship Treasurer, Australian and New Zealand Society for Immunology (2018–2022) Executive Committee Member Collaborations span institutions in Australia, Germany, and Denmark, with expertise in flow cytometry , mass spectrometry , and MHC-peptide interactions .

Andreas Lundqvistمشاهده پروفایل

استاد

• Cancer and Oncology
• Cell and Molecular Biology
• Immunology in the medical area

Andreas Lundqvist is a Professor at the Department of Oncology-Pathology, Karolinska Institutet. His research focuses on understanding mechanisms of immune escape in solid tumors, particularly investigating NK and T cell regulation. He leads the Cell-based Immune Therapy for Cancer group, aiming to develop novel immunotherapies. Education & Roles: PhD in Immunology, Karolinska Institutet (2003) Professor since 2023; Associate Professor (2012–2023); Assistant Professor (2009–2012) Prior roles include Staff Scientist and Research Fellow at the National Institutes of Health (NIH) (2003–2008) Research Interests: Lundqvist's work targets immune evasion in cancer, with emphasis on NK and T cell dynamics. His group explores tumor microenvironment interactions, immune checkpoint modulation, and biomarker discovery. Recent studies focus on renal cell carcinoma, melanoma, and Hodgkin lymphoma. Grants & Funding: Swedish Childhood Cancer Fund (2024–2025) Swedish Research Council (2023–2026) Swedish Cancer Society (2022–2024) Advising & Labs: Lundqvist supervises a research group including PhD students and postdoctoral fellows. Notable alumni include Dhifaf Sarhan (Karolinska Institutet) and Erik Wennerberg (The Institute of Cancer Research).

• Cancer Immunology
• Antigen Processing and Presentation
• T Cell Immunology
• +۳ مورد دیگر

Dr. Emma Reeves is a Lecturer in Cancer Immunology at the University of Southampton, affiliated with the Department of Cancer Sciences. Her research focuses on antigen processing mechanisms, T cell responses, and tumor immunology, particularly exploring the role of ERAP1 in disease contexts ranging from cancer to autoimmune conditions. She currently supervises two PhD students in Cancer Sciences and teaches topics related to immunology and cancer biology. Her key research interests include understanding how ERAP1 polymorphisms influence immune responses in viral infections, cancer progression, and autoimmune disorders. This work bridges molecular immunology and clinical applications, aiming to develop therapeutic strategies targeting antigen processing pathways. Publications highlight her contributions to elucidating ERAP1's role in shaping MHC class I peptide repertoires, HPV-associated tumor immunity, and the prognostic significance of ERAP1 variants in cancer. While no specific awards are listed, her research has been published in high-impact journals such as Cancer Immunology Research and Journal of Hepatology . Dr. Reeves collaborates with interdisciplinary teams investigating tumor immune evasion mechanisms and translational immunotherapies. She maintains an active role in guiding early-career researchers through her PhD supervision and contributes to advancing our understanding of immune system dynamics in health and disease.

Kristen W. Lynchمشاهده پروفایل

استاد

• RNA Biology
• Alternative Splicing
• Alternative Polyadenylation
• +۷ مورد دیگر

Kristen W. Lynch, PhD, is the Benjamin Rush Professor of Biochemistry and Chair of the Department of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania. She leads research at the Lynch Lab and co-directs the Institute for RNA Innovation , focusing on RNA processing mechanisms in human immune responses. Education: Harvard University (B.A. 1990, Ph.D. 1996) Postdoctoral Training: University of California, San Francisco (1997-2001) Her work bridges RNA splicing , alternative polyadenylation , and gene regulation in immune cells and cancer. She discovered kinase pathways controlling RNA-binding protein (RBP) activity and demonstrated how antigen stimulation and viral infections reprogram splicing networks to modulate immunity. Collaborative studies with oncologists revealed splicing defects phenocopying genetic mutations in leukemias and identified therapeutic vulnerabilities in RNA processing . Her recent publications highlight TREX-2 complex in mRNA export, hnRNP L repressing cryptic exons, and DDX39B structural analysis . Collaborations span RNA-Seq , splicing codes , and epithelial cell post-transcriptional programs . She explores spliceosomal assembly mechanisms and signal-responsive RBPs in T cells and influenza pathogenesis.

• Gene Therapy
• Immunotherapy
• Immunobiology
• +۵ مورد دیگر

Associate Professor Grant Logan is a Senior Lecturer at the University of Sydney and a Research Scientist at the Children’s Medical Research Institute. He also serves as an Honorary Hospital Scientist at the Children’s Hospital at Westmead, where he develops serological tools to assess gene therapy eligibility. University of Sydney Children’s Medical Research Institute Children’s Hospital at Westmead Logan’s research focuses on the immunobiology of gene therapies using adeno-associated virus (AAV) vectors . His work explores host-vector interactions, pre-existing immunity, and strategies to enhance gene therapy efficacy for autoimmune and rheumatological disorders . He has contributed to understanding AAV vector tolerogenicity and immune modulation. Recent publications highlight his work on AAV vector engineering for liver-specific expression, DNaseI delivery in lupus models, and anti-AAV antibody characterization in spinal muscular atrophy patients. Honorary Hospital Scientist at Children’s Hospital at Westmead Member, Gene Therapy Technical Advisory Committee to Australian Office of the Gene Technology Regulator Collaborations with biotech industry and multiple patents Key grants include: 2024: NHMRC Ideas Grant for AAV bioengineering to escape pre-existing immunity 2022: NHMRC Ideas Grant for pharmaco-genetic autoimmune kidney disease treatment 2020: NHMRC Ideas Grant for anti-capsid immunity in SMA gene therapy

• Cancer Biology
• Virology
• Precision Medicine
• +۳ مورد دیگر

Kien Pham is a Research Scientist in Pathology at Yale School of Medicine, serving as Operations Manager for the YSM Biobank. She holds a Ph.D. in Biomedical Sciences from the University of Florida and completed postdoctoral training under Prof. Chen Liu. Her research focuses on cancer metastasis, precision medicine, and viral hepatitis, with contributions to SARS-CoV-2 genomic studies. Previously, she was an Assistant Professor at Rutgers New Jersey Medical School. Education: B.S. (2006, Molecular and Cellular Biology), M.S. (2008, Applied Biosciences), Ph.D. (2013, Biomedical Sciences) from the University of Arizona and University of Florida. Research Interests: Her work spans cancer biology, virology, and epigenetics, with recent emphasis on Omicron variant dynamics, CAR-NK therapy for hepatocellular carcinoma, and epigenetic drivers of liver disease. She leads collaborative projects on viral evolution and precision oncology. Key Achievements: Published over 20 peer-reviewed articles and book chapters. Awards include AIMS Awards (2020), Experimental Pathology Innovative Grant (2014), and Medical Guild Research Incentive Award (2010). Labs & Affiliations: Chen Liu Lab, Yale Pathology Department, YSM Biobank. Active in translational research and global health initiatives.